Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder
Abstract
Sulforaphane (SF), an isothiocyanate in broccoli, has potential benefits relevant to autism spectrum disorder (ASD) through its effects on several metabolic and immunologic pathways. Previous clinical trials of oral SF demonstrated positive clinical effects on behavior in young men and changes in urinary metabolomics in children with ASD.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 25, 2021
- Source ID
- 10.1186/s13229-021-00447-5
Entities
People
- Andrew W. Zimmerman
- Anita A. Panjwani
- Ann Foley
- Eileen Diggins
- Hua Liu
- Indrapal N. Singh
- Jed W. Fahey
- Kanwaljit Singh
- Li-ching Lee
- Richard E Frye
- S. Jill James
- Stepan Melnyk
- Susan L. Connors
Organizations
- United States Department of Defense